维普中文期刊产品整合服务
21篇 您的检索式:作者名="Moosmann N"
    题名 作者 年代 出处 被引量
1Cetuximab plus oxalip latin2based chemotherapy in the treatment of colorectal cancer显示文摘Moosmann N Heinemann V 2008Expert Rev Anticancer Ther2008,8,3:1
2B cells immortalized by a mini-Epstein-Ban' virus encoding a foreign antigen efficiently reacti- vate specific cytotoxic T cells 显示文摘Moosmann A Khan N Cobbold M 2002Blood2002,100,5:1
3B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells 显示文摘Moosmann A Khan N Cobbold M 2002Blood2002,100,5:1
4Neoadjuvant and adjuant thera- pies for solid tumours 显示文摘HEINEMANN V MOOSMANN N 2007MMW Fortschr Med2007,149,3536:1
5Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer显示文摘MOOSMANN N HEINEMANN V 2008Clin Colorectal Cancer2008,7,2:1
6B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells 显示文摘Moosmann A Khan N Cobbold M 2002Blood2002,100,5:1
7The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status 显示文摘Stlntzing S Heinemann V Moosmann N 2009Dtsch Arztebl Int2009,106,12:1
8The treatment of colorectal ear-ci noma with monoclonal antibodies:the importance of KRAS mutation analysis and EGFR status显示文摘Stintzing S Heinemann V Moosmann N 2009Dtsch Arztebl Int2009,106,12:1
9Neoadjuvant and adjuvant therapies for solid tumours显示文摘Heinemann V Moosmann N 2007MMW Fortschr Med2007,149,3556:1
10Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104- a randomized trial of the German AIO CRC study group显示文摘Moosmann N Von Weikersthal LF Vehling-Kaiser U 2011J Clin Oncol2011,29,8:1
11The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status 显示文摘Stintzing S Heinemann V Moosmann N 2009Deutsches Arzteblatt Int2009,106,12:1
12B cells immortalized by a mini-Epstein-Barr vires encoding a foreign antigen efficiently reactivate specific cytotoxic T cells显示文摘Moosmann A Khan N Cobbold M 2002Blood2002,100,5:1
13The treatment of colorectal carcinoma with monoclonal antibodies:the importance of KRAS mutation analysis and EGFR status显示文摘Stintzing S Heinemann V Moosmann N 2009Dtsch Arztebl Int2009,106,12:1
14Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid,topical antibiotic and topical corticosteroid 显示文摘Wollenberg A Moosmann N Kroth J 2007Hautarzt2007,58,7:1
15Neoadjuvant and adjuvant therapies for solid tumours显示文摘HeinemannV Moosmann N 2007MMW Fortsehr Med2007,149,3536:1
16Cetuximab plus oxaliplatin-based chemotherapy in the treatment of coloreetal cancer 显示文摘Moosmann N Heinemann V 2008Expert Rev Anticancer Ther2008,8,3:1
17Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer显示文摘Moosmann N Heinemann V 2008Expert Rev Anticancer Ther2008,8,3:1
18The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status显示文摘Stintzing S Heinemann V Moosmann N 2009Dtsch Arztebl Int2009,106,:1
19Development and vali- dation of anLC-MS/MS method for quantification of A9-te- trahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair显示文摘Roth N Moosmann B Auwarter V 2013J Mass Spectrom2013,,48:1
20Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer:AIO KRK-0104-A Randomized Trial of the German AIO CRC Study Group显示文摘Moosmann N Von Weikersthal LF Vehling-Kaiser U 2011J Clin Oncol2011,29,8:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费